S 613 · 111th Congress · Health
A bill to prohibit the use of Federal funds to approve certain biologics license applications by the Food and Drug Administration.
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2009-03-17)
Plain Language Summary
[AI summary unavailable — showing source text]
Prohibits the use of funds by the Food and Drug Administration (FDA) to process a biologics license application for any biologic product that is, bears, or contains an agent or toxin listed in federal regulations as dangerous to life, property, or the environment and that has been marketed, sold, or distributed to the Islamic Republic of Iran by an entity under investigation for potential violations of the Iran Sanctions Act of 1996.…
Summarized by Claude AI · Non-partisan · For informational purposes only